Logo image of ALEXP.PA

ONE EXPERIENCE (ALEXP.PA) Stock Fundamental Analysis

EPA:ALEXP - Euronext Paris - Matif - FR0013266772 - Common Stock - Currency: EUR

1.03  +0.03 (+3%)

Fundamental Rating

2

Overall ALEXP gets a fundamental rating of 2 out of 10. We evaluated ALEXP against 57 industry peers in the Hotels, Restaurants & Leisure industry. Both the profitability and financial health of ALEXP have multiple concerns. ALEXP has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year ALEXP has reported negative net income.
ALEXP had a positive operating cash flow in the past year.
ALEXP.PA Yearly Net Income VS EBIT VS OCF VS FCFALEXP.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 200K -200K 400K -400K -600K -800K

1.2 Ratios

Looking at the Return On Assets, with a value of -8.82%, ALEXP is doing worse than 78.57% of the companies in the same industry.
With a Return On Equity value of -15.81%, ALEXP is not doing good in the industry: 60.71% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -8.82%
ROE -15.81%
ROIC N/A
ROA(3y)-3.71%
ROA(5y)N/A
ROE(3y)-7.11%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALEXP.PA Yearly ROA, ROE, ROICALEXP.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 -2 -4 -6 -8

1.3 Margins

ALEXP's Gross Margin of 39.77% is in line compared to the rest of the industry. ALEXP outperforms 41.07% of its industry peers.
ALEXP's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for ALEXP so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 39.77%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.49%
GM growth 5YN/A
ALEXP.PA Yearly Profit, Operating, Gross MarginsALEXP.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 20 -20 40 -40 60 80

3

2. Health

2.1 Basic Checks

ALEXP does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALEXP has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, ALEXP has an improved debt to assets ratio.
ALEXP.PA Yearly Shares OutstandingALEXP.PA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2M 4M 6M 8M
ALEXP.PA Yearly Total Debt VS Total AssetsALEXP.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 5M 10M 15M

2.2 Solvency

ALEXP has an Altman-Z score of 0.85. This is a bad value and indicates that ALEXP is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of ALEXP (0.85) is worse than 69.64% of its industry peers.
The Debt to FCF ratio of ALEXP is 5.47, which is a neutral value as it means it would take ALEXP, 5.47 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 5.47, ALEXP is doing good in the industry, outperforming 66.07% of the companies in the same industry.
ALEXP has a Debt/Equity ratio of 0.27. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.27, ALEXP is in the better half of the industry, outperforming 73.21% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF 5.47
Altman-Z 0.85
ROIC/WACCN/A
WACC6.68%
ALEXP.PA Yearly LT Debt VS Equity VS FCFALEXP.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 2M 4M 6M 8M

2.3 Liquidity

ALEXP has a Current Ratio of 0.95. This is a bad value and indicates that ALEXP is not financially healthy enough and could expect problems in meeting its short term obligations.
ALEXP's Current ratio of 0.95 is in line compared to the rest of the industry. ALEXP outperforms 44.64% of its industry peers.
A Quick Ratio of 0.95 indicates that ALEXP may have some problems paying its short term obligations.
ALEXP has a Quick ratio (0.95) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 0.95
Quick Ratio 0.95
ALEXP.PA Yearly Current Assets VS Current LiabilitesALEXP.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 1M 2M 3M 4M

3

3. Growth

3.1 Past

The earnings per share for ALEXP have decreased strongly by -76.86% in the last year.
Looking at the last year, ALEXP shows a very strong growth in Revenue. The Revenue has grown by 84.09%.
The Revenue has been growing by 91.23% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-76.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-103%
Revenue 1Y (TTM)84.09%
Revenue growth 3Y91.23%
Revenue growth 5YN/A
Sales Q2Q%67.88%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALEXP.PA Yearly Revenue VS EstimatesALEXP.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 1M 2M 3M 4M 5M

1

4. Valuation

4.1 Price/Earnings Ratio

ALEXP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALEXP.PA Price Earnings VS Forward Price EarningsALEXP.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

ALEXP's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 27.11
EV/EBITDA N/A
ALEXP.PA Per share dataALEXP.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ALEXP!.
Industry RankSector Rank
Dividend Yield N/A

ONE EXPERIENCE

EPA:ALEXP (5/23/2025, 7:00:00 PM)

1.03

+0.03 (+3%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners13.57%
Inst Owner ChangeN/A
Ins Owners37.9%
Ins Owner ChangeN/A
Market Cap9.43M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.55
P/FCF 27.11
P/OCF 17.97
P/B 1.32
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.12
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.04
FCFY3.69%
OCF(TTM)0.06
OCFY5.56%
SpS0.66
BVpS0.78
TBVpS-0.08
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.82%
ROE -15.81%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 39.77%
FCFM 5.73%
ROA(3y)-3.71%
ROA(5y)N/A
ROE(3y)-7.11%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.49%
GM growth 5YN/A
F-Score5
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF 5.47
Debt/EBITDA N/A
Cap/Depr 63.21%
Cap/Sales 2.91%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.95
Quick Ratio 0.95
Altman-Z 0.85
F-Score5
WACC6.68%
ROIC/WACCN/A
Cap/Depr(3y)180.68%
Cap/Depr(5y)N/A
Cap/Sales(3y)18.68%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-76.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-103%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)84.09%
Revenue growth 3Y91.23%
Revenue growth 5YN/A
Sales Q2Q%67.88%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-23.04%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y3727.27%
OCF growth 3YN/A
OCF growth 5YN/A